Abstract: An air conditioner and a method for controlling the same are disclosed. The air conditioner implements a multistage expansion scheme by implementing serial connection between electronic expansion valves including in the R410A refrigerant-based air conditioner, and thus guarantees an optimum compression ratio in all cooling/heating load regions. Therefore, although cycle characteristics are changed by changing R410A refrigerant to R32 refrigerant, the air conditioner optimizes the cycle simply by controlling a degree of opening of electronic expansion valves, respectively. As described above, since the cycle optimization is implemented using the multistage expansion scheme in which legacy electronic expansion valves are coupled in series, the design modification is minimized without design modification of requisite constituent elements such as a heat exchanger, system implementation is facilitated, resulting in high efficiency in cost and productivity.

Abstract: An anti-Ang2 antibody or an antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang2) and complexes with a Tie2 receptor through Ang2, and methods of using the same.

Abstract: An air conditioning device is provided. The air conditioning device includes: a sensor configured to sense a driving state of the air conditioning device and ambient air information of the air conditioning device; a processor configured to calculate temperature and humidity information of discharged air on the basis of the information sensed by the sensor, and calculate an amount of dehumidification on the basis of the calculated temperature and humidity information; and a display configured to provide the calculated amount of dehumidification.

Abstract: An air conditioner maintains a pleasant indoor temperature or humidity without making a user feel wind speed. The air conditioner includes a housing comprising a discharge plate having a plurality of discharge holes and an outlet, a heat exchanger configured to exchange heat with air introduced into the housing, a blower fan configured to allow the heat-exchanged air to flow through the discharge plate or the outlet, a discharge blade having a plurality of blade holes and configured to open and close the outlet; and a controller configured to control the heat-exchanged air to be discharged through the discharge holes and the blade holes when the outlet is closed and configured to reduce a frequency of a compressor to a predetermined value when an indoor relative humidity is within a predetermined range.

Abstract: A fusion polypeptide capable of binding simultaneously to angiopoietin 2, VEGF-C and VEGF-D; or capable of binding simultaneously to VEGF-C and VEGF-D, and methods for the preparation and use thereof.

Abstract: An air conditioner and a method for controlling the same are disclosed. The air conditioner implements a multistage expansion scheme by implementing serial connection between electronic expansion valves including in the R410A refrigerant-based air conditioner, and thus guarantees an optimum compression ratio in all cooling/heating load regions. Therefore, although cycle characteristics are changed by changing R410A refrigerant to R32 refrigerant, the air conditioner optimizes the cycle simply by controlling a degree of opening of electronic expansion valves, respectively. As described above, since the cycle optimization is implemented using the multistage expansion scheme in which legacy electronic expansion valves are coupled in series, the design modification is minimized without design modification of requisite constituent elements such as a heat exchanger, system implementation is facilitated, resulting in high efficiency in cost and productivity.

Abstract: An anti-Ang2 antibody or an antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang2) and complexes with a Tie2 receptor through Ang2, and methods of using the same.

Abstract: An Ang2 specific antibody, a method of inhibiting angiogenesis or a method of treating a disease related to the activation and/or overproduction of Ang2 using the antibody, and a composition for diagnosing a disease related to the activation and/or overproduction of Ang2 including the antibody.

Abstract: An air conditioner maintains a pleasant indoor temperature or humidity without making a user feel wind speed. The air conditioner includes a housing comprising a discharge plate having a plurality of discharge holes and an outlet, a heat exchanger configured to exchange heat with air introduced into the housing, a blower fan configured to allow the heat-exchanged air to flow through the discharge plate or the outlet, a discharge blade having a plurality of blade holes and configured to open and close the outlet; and a controller configured to control the heat-exchanged air to be discharged through the discharge holes and the blade holes when the outlet is closed and configured to reduce a frequency of a compressor to a predetermined value when an indoor relative humidity is within a predetermined range.

Abstract: An anti-Ang2 antibody or an antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang2) and complexes with a Tie2 receptor through Ang2, and methods of using the same.

Abstract: An air conditioning device is provided. The air conditioning device includes: a sensor configured to sense a driving state of the air conditioning device and ambient air information of the air conditioning device; a processor configured to calculate temperature and humidity information of discharged air on the basis of the information sensed by the sensor, and calculate an amount of dehumidification on the basis of the calculated temperature and humidity information; and a display configured to provide the calculated amount of dehumidification.

Abstract: A fusion polypeptide capable of binding simultaneously to angiopoietin 2, VEGF-C and VEGF-D; or capable of binding simultaneously to VEGF-C and VEGF-D, and methods for the preparation and use thereof.

Abstract: A fusion polypeptide capable of binding simultaneously to angiopoietin 2, VEGF-C and VEGF-D; or capable of binding simultaneously to VEGF-C and VEGF-D, and methods for the preparation and use thereof.

Abstract: An Ang2 specific antibody, a method of preventing and/or treating a disease related to the activation and/or overproduction (overexpression) of Ang2 by administering the antibody to a subject, and a method of screening a candidate substance for diagnosing, preventing, or treating a disease related to activation or overproduction of Ang2.

Abstract: An antibody or antigen-binding fragment thereof that specifically binds to and inhibits VEGF-C and uses thereof in a method of inhibiting angiogenesis and a method of preventing, treating, and/or diagnosing a disease associated with activation and/or overexpression of VEGF-C, using the antibody, and a method of detecting the presence of VEGF-C in a sample.

Abstract: An anti-Ang2 antibody or an antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang2) and complexes with a Tie2 receptor through Ang2, and methods of using the same.

Abstract: An Ang2 specific antibody, a method of preventing and/or treating a disease related to the activation and/or overproduction (overexpression) of Ang2 by administering the antibody to a subject, and a method of screening a candidate substance for diagnosing, preventing, or treating a disease related to activation or overproduction of Ang2.

Abstract: A polypeptide, antagonist, and antibody that specifically bind to and inhibit VEGF-C and uses thereof in a method of inhibiting angiogenesis and a method of preventing, treating, and/or diagnosing a disease associated with activation and/or overexpression of VEGF-C, using the antibody, and a method of detecting the presence of VEGF-C in a sample.

Abstract: An Ang2 specific antibody, a method of inhibiting angiogenesis or a method of treating a disease related to the activation and/or overproduction of Ang2 using the antibody, and a composition for diagnosing a disease related to the activation and/or overproduction of Ang2 including the antibody.

Abstract: A fusion polypeptide capable of binding simultaneously to angiopoietin 2, VEGF-C and VEGF-D; or capable of binding simultaneously to VEGF-C and VEGF-D, and methods for the preparation and use thereof.